A compound depicted by the formula below, or a pharmaceutically acceptable salt or solvate thereof. wherein, R 1 represents (1) a C 3-6 alkyl group,(2) a C 1-6 alkyl group substituted with one or more substituent group(s) selected from those consisting a halogen atom, etc., (3) a C 3-10 non-aromatic cyclic hydrocarbon group or a 5- to 6-membered non-aromatic heterocyclic group which respectively is optionally substituted with one or more substituent group(s) selected from those consisting an oxo group, etc., (4) an aromatic cyclic hydrocarbon group substituted with one or more substituent selected from the group consisting halogen atom and C 1-4 alkoxy group； X represents NH, O, or S； Y represents CH or N； Z represents N or a C-R 2 ； R 2 represents (1) hydrogen atom, (2) a C 1-6 alkyl group, a C 2-6 alkenyl group or a C 2-6 alkynyl group that respectively is optionally substituted with one or more substituent group(s) selected from among those consisting (a) a halogen atom, etc., or (3) a C 5-6 non-aromatic cyclic hydrocarbon group or a 5- to 6-membered non-aromatic heterocyclic group optionally substituted； ring A represents a benzene ring optionally substituted； ring B represents a benzene ring optionally substituted.
